Matches in Nanopublications for { ?s ?p "DDI between Tamsulosin and Lapatinib - Lapatinib, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Lapatinib is initiated, discontinued, or dose changed. [drugbank_resource:DB00706_DB01259]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00706_DB01259 label "DDI between Tamsulosin and Lapatinib - Lapatinib, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Lapatinib is initiated, discontinued, or dose changed. [drugbank_resource:DB00706_DB01259]" assertion.